SCHEMBL17034985

SCHEMBL17034985

c1ccc(-c2nc3ccccc3c3c2cc(-c2c4ccccc4c(-c4cccc(-c5ccncc5)n4)c4ccccc24)c2ccccc23)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
KDM4E B2RXH2 4/20 0.42
MAPT P10636 3/20 0.42
HPGD P15428 3/20 0.42
DHODH Q02127 1/20 0.40
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
LMNA P02545 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
MAPK1 P28482 1/20 0.38
RECQL P46063 1/20 0.38
CYP2C9 P11712 5/20 0.37
CYP3A4 P08684 3/20 0.37
RAB9A P51151 2/20 0.37
NPC1 O15118 1/20 0.37
CYP1A2 P05177 1/20 0.37
AR P10275 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C19 P33261 1/20 0.37
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18907340 0.91 KDM4E (0.41) ALDH1A1KDM4EMAPTHPGDDHODH
SCHEMBL17035085 0.91 ALDH1A1 (0.39) ALDH1A1KDM4EMAPTHPGDDHODH
SCHEMBL19009712 0.86 KDM4E (0.38) ALDH1A1KDM4EMAPTHPGDDHODH
SCHEMBL18907190 0.86 KDM4E (0.43) ALDH1A1KDM4EMAPTHPGDDHODH
SCHEMBL17035021 0.81 ALDH1A1 (0.46) ALDH1A1KDM4EMAPTHPGDDHODH
SCHEMBL17034989 0.81 NPC1 (0.43) ALDH1A1KDM4EMAPTHPGDDHODH
SCHEMBL18201302 0.81 KDM4E (0.46) ALDH1A1KDM4EMAPTHPGDDHODH
SCHEMBL18201204 0.80 KDM4E (0.44) ALDH1A1KDM4EMAPTHPGDDHODH
SCHEMBL17035045 0.80 KDM4E (0.46) ALDH1A1KDM4EMAPTHPGDDHODH
SCHEMBL18200663 0.79 KDM4E (0.43) ALDH1A1KDM4EMAPTHPGDDHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 ALDH1A1 753/4885KDM4E 3143/4885MAPT 1406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.